Literature DB >> 20034477

Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization.

Ruth Sharf1, Douglas J Guarnieri, Jane R Taylor, Ralph J DiLeone.   

Abstract

Orexin (or hypocretin) has been implicated in mediating drug addiction and reward. Here, we investigated orexin's contribution to morphine-induced behavioral sensitization and place preference. Orexin-/- (OKO) mice and littermate wild-type (WT) controls (n=56) and C57BL/6J mice (n=67) were tested for chronic morphine-induced locomotor sensitization or for conditioned place preference (CPP) for a morphine- or a cocaine-paired environment. C57BL/6J mice received the orexin receptor 1 (Ox1r) antagonist, SB-334867, prior to test sessions. OKO mice did not significantly differ from WT controls in locomotor activity following acute- or chronic-morphine treatments. Similarly, mice treated with the Ox1r antagonist did not differ from vehicle controls in locomotor activity following acute- or chronic-morphine treatments. In contrast, while OKO mice did not differ from WT controls in preference for a morphine-paired environment, the Ox1r antagonist significantly attenuated place preference for a morphine-, but not a cocaine-paired, environment. These data suggest that orexin action is not required for locomotor responses to acute and chronic morphine, but Ox1r signaling can influence morphine-seeking in WT animals. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20034477      PMCID: PMC2822072          DOI: 10.1016/j.brainres.2009.12.035

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

1.  Neurons containing hypocretin (orexin) project to multiple neuronal systems.

Authors:  C Peyron; D K Tighe; A N van den Pol; L de Lecea; H C Heller; J G Sutcliffe; T S Kilduff
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

2.  Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems.

Authors:  Y Date; Y Ueta; H Yamashita; H Yamaguchi; S Matsukura; K Kangawa; T Sakurai; M Yanagisawa; M Nakazato
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

4.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

Authors:  E Carboni; A Imperato; L Perezzani; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

5.  Distribution of orexin neurons in the adult rat brain.

Authors:  T Nambu; T Sakurai; K Mizukami; Y Hosoya; M Yanagisawa; K Goto
Journal:  Brain Res       Date:  1999-05-08       Impact factor: 3.252

6.  Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.

Authors:  Y Ishii; J E Blundell; J C G Halford; N Upton; R Porter; A Johns; P Jeffrey; S Summerfield; R J Rodgers
Journal:  Behav Brain Res       Date:  2005-02-28       Impact factor: 3.332

7.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

8.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.

Authors:  D J Henry; M A Greene; F J White
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

9.  A role for lateral hypothalamic orexin neurons in reward seeking.

Authors:  Glenda C Harris; Mathieu Wimmer; Gary Aston-Jones
Journal:  Nature       Date:  2005-08-14       Impact factor: 49.962

10.  Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.

Authors:  P W Kalivas; P Duffy
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

View more
  34 in total

1.  Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Authors:  Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

Review 2.  Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Hypocretin/orexin involvement in reward and reinforcement.

Authors:  Rodrigo A España
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

4.  Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.

Authors:  Brennon R Luster; Elizabeth S Cogan; Karl T Schmidt; Dipanwita Pati; Melanie M Pina; Kedar Dange; Zoé A McElligott
Journal:  Addict Biol       Date:  2019-04-09       Impact factor: 4.280

Review 5.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

Review 6.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 7.  The hypocretin/orexin system: implications for drug reward and relapse.

Authors:  Ainhoa Plaza-Zabala; Rafael Maldonado; Fernando Berrendero
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

8.  Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine.

Authors:  Jessica K Shaw; Mark J Ferris; Jason L Locke; Zachary D Brodnik; Sara R Jones; Rodrigo A España
Journal:  Addict Biol       Date:  2016-08-02       Impact factor: 4.280

Review 9.  Role of orexin/hypocretin in dependence and addiction.

Authors:  Ruth Sharf; Maysa Sarhan; Ralph J Dileone
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

10.  The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.

Authors:  David A Perrey; Ann M Decker; Jun-Xu Li; Brian P Gilmour; Brian F Thomas; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  Bioorg Med Chem       Date:  2015-07-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.